Famciclovir treatment of chronic delta hepatitis

Yurdaydin, C; Bozkaya, H; Gurel, SELİM; Tillmann, HL; Aslan, N; Okcu-Heper, A; Erden, E; Yalcin, K; Iliman, N; Uzunalimoglu, O; Manns, MP; Bozdayi, AM

doi:10.1016/s0168-8278(02)00162-9

Famciclovir treatment of chronic delta hepatitis

Yurdaydin C., Bozkaya H., Gurel S., Tillmann H., Aslan N., Okcu-Heper A., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.37, sa.2, ss.266-271, 2002 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 37 Sayı: 2
Basım Tarihi: 2002
Doi Numarası: 10.1016/s0168-8278(02)00162-9
Dergi Adı: JOURNAL OF HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.266-271
Anahtar Kelimeler: delta hepatitis, treatment, famciclovir, hepatitis B virus (HBV) DNA, hepatitis delta virus RNA, B VIRUS, LIVER-TRANSPLANTATION, LAMIVUDINE, INFECTION, PENCICLOVIR, ANTIGEN, REPLICATION, INTERFERON, INHIBITION, PATTERN
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background/Aims: Interferon is the only established therapy for chronic delta hepatitis and alternative treatment options are an urgent need. Since successful treatment of a case of post-transplant delta hepatitis with the nucleoside analogue famciclovir had been reported, a pilot study was undertaken to evaluate the use of famciclovir in the treatment of chronic delta hepatitis.